TNFRSF9 and neoplasm: Of note, more MC38 tumour-derived TILs expressed CD137 on day 28 after tumour inoculation than on day 11 after tumour inoculation (Supplementary Fig. 3f), suggesting that CD137 on TILs was upregulated with tumour progression.